Latest Sandoz News & Updates

See the latest news and media coverage for Sandoz. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Sandoz

Global generic and biosimilar medicines company

sandoz.com
Headquarters
Basel, Switzerland
Company type
Public company
Number of employees
10,000+
Industry
Pharmaceuticals

Last updated

Latest news about Sandoz

In short: Sandoz launched Enzeevu in the US and announced a multi-year private-label agreement

Company announcements

Sandoz

Sandoz launches Enzeevu in the US

The biosimilar treats retinal diseases including nAMD and DME, and a multi-year private-label agreement will add committed US volumes from mid-2027.

Sandoz

Sandoz reports 5% net-sales growth in Q3 2026

Biosimilar net sales rise 17% at constant currencies, while full-year net-sales guidance narrows to 5-6% and core-EBITDA margin guidance is upgraded to 23.0-23.5%.

Sandoz

Sandoz receives Health Canada approval for generic semaglutide

The GLP-1 injection is a generic version of Ozempic for adults with type-2 diabetes, available in three dose strengths via two pen presentations.

Unlock all announcements with a

Media coverage

Financial Times

Sandoz enters new era as standalone global leader and European champion in generic and biosimilar medicines

Spin-off from Novartis successfully completed with first trading day today on SIX Swiss Exchange; Sandoz shares included in key market indices Standalone Sandoz committed to...

Unlock all articles with a

Never miss news about Sandoz

Track Sandoz and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.